Published in J Virol on May 01, 1991
Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol (1994) 2.48
The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J (2002) 2.41
Structural rearrangements in the membrane penetration protein of a non-enveloped virus. Nature (2004) 2.05
Atomic model of an infectious rotavirus particle. EMBO J (2010) 1.79
Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science (2009) 1.66
Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol (1996) 1.56
Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J Virol (2001) 1.51
Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. J Virol (1993) 1.50
Interaction of rotavirus particles with liposomes. J Virol (1992) 1.39
Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol (2012) 1.38
Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J Virol (1998) 1.37
Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. J Virol (1994) 1.35
Rotaviruses induce an early membrane permeabilization of MA104 cells and do not require a low intracellular Ca2+ concentration to initiate their replication cycle. J Virol (1997) 1.32
Structural insights into the coupling of virion assembly and rotavirus replication. Nat Rev Microbiol (2012) 1.30
Cleavage of rhesus rotavirus VP4 after arginine 247 is essential for rotavirus-like particle-induced fusion from without. J Virol (1998) 1.27
Liposome-mediated transfection of intact viral particles reveals that plasma membrane penetration determines permissivity of tissue culture cells to rotavirus. J Clin Invest (1992) 1.24
Interactions between the two surface proteins of rotavirus may alter the receptor-binding specificity of the virus. J Virol (1996) 1.22
Characterization of human serotype 1 astrovirus-neutralizing epitopes. J Virol (1997) 1.22
Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins. J Virol (2006) 1.20
Rotavirus interaction with isolated membrane vesicles. J Virol (1994) 1.18
The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J Virol (2000) 1.16
A rotavirus spike protein conformational intermediate binds lipid bilayers. J Virol (2009) 1.10
Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice. J Clin Microbiol (1996) 1.10
Rotavirus-induced fusion from without in tissue culture cells. J Virol (1995) 1.10
Mapping the hemagglutination domain of rotaviruses. J Virol (1995) 1.07
Virus-like particle-induced fusion from without in tissue culture cells: role of outer-layer proteins VP4 and VP7. J Virol (1997) 1.07
Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event. J Virol (2001) 1.04
Rhesus rotavirus entry into a polarized epithelium is endocytosis dependent and involves sequential VP4 conformational changes. J Virol (2010) 1.00
Molecular characterization of novel G5 bovine rotavirus strains. J Clin Microbiol (2006) 1.00
VP7 and VP4 genotyping of human group A rotavirus in Buenos Aires, Argentina. J Clin Microbiol (2000) 0.99
Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation. J Virol (2002) 0.99
Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses. J Clin Invest (2013) 0.94
Effect of mutations in VP5 hydrophobic loops on rotavirus cell entry. J Virol (2010) 0.94
Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response. PLoS Pathog (2010) 0.92
Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cells. J Virol (1998) 0.91
Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse. J Clin Invest (1992) 0.87
Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus. Biochem J (2003) 0.85
Structural basis of rotavirus strain preference toward N-acetyl- or N-glycolylneuraminic acid-containing receptors. J Virol (2012) 0.85
Characterization of the interaction between VP8 of bovine rotavirus C486 and cellular components on MA-104 cells and erythrocytes. Can J Vet Res (1998) 0.82
Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry. J Virol (2011) 0.81
In silico study of rotavirus VP7 surface accessible conserved regions for antiviral drug/vaccine design. PLoS One (2012) 0.81
A neutralizing monoclonal antibody to bovine rotavirus VP8 neutralizes rotavirus infection without inhibiting virus attachment to MA-104 cells. Can J Vet Res (1998) 0.79
The shift from low to high non-structural protein 1 expression in rotavirus-infected MA-104 cells. Mem Inst Oswaldo Cruz (2013) 0.77
Selection of single-chain antibodies against the VP8* subunit of rotavirus VP4 outer capsid protein and their expression in Lactobacillus casei. Appl Environ Microbiol (2004) 0.77
Expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8* sialic acid-binding domain of porcine rotavirus strain OSU. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.75
Functions of Antibodies. Microbiol Spectr (2014) 0.75
Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus. Sci Rep (2016) 0.75
Expression of the Multimeric and Highly Immunogenic Brucella spp. Lumazine Synthase Fused to Bovine Rotavirus VP8d as a Scaffold for Antigen Production in Tobacco Chloroplasts. Front Plant Sci (2015) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J Virol (1988) 4.13
Antigenic mapping of the surface proteins of rhesus rotavirus. Virology (1986) 3.80
Three-dimensional structure of rotavirus. J Mol Biol (1988) 3.79
Protein sigma 1 is the reovirus cell attachment protein. Virology (1981) 3.48
Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. J Virol (1989) 3.20
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses. J Gen Virol (1985) 3.12
Molecular basis of rotavirus virulence: role of gene segment 4. J Virol (1986) 3.08
Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science (1988) 3.08
Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J Virol (1986) 2.97
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy. Nature (1990) 2.77
Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol (1988) 2.72
Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proc Natl Acad Sci U S A (1986) 2.71
Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J Virol (1988) 2.61
Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses. J Virol (1986) 2.54
The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science (1989) 2.40
Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. Virology (1983) 2.30
A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus. J Virol (1988) 2.29
Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization. J Virol (1983) 2.18
Mechanisms of neutralization of animal viruses. J Gen Virol (1984) 2.16
Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. Virology (1976) 2.09
THE INTRACELLULAR FATE OF RABBITPOX VIRUS RENDERED NONINFECTIOUS BY VARIOUS REAGENTS. Virology (1964) 2.06
Role of VP3 in human rotavirus internalization after target cell attachment via VP7. J Virol (1988) 2.01
Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein. J Virol (1985) 1.97
The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol (1989) 1.80
Molecular determinant of rotavirus neutralization and protection. Adv Virus Res (1989) 1.65
Purification of an outer capsid glycoprotein of neonatal calf diarrhea virus and preparation of its antisera. Infect Immun (1983) 1.63
Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein. Virology (1983) 1.61
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol (1989) 1.58
Epitope-specific immune responses to rotavirus vaccination. Gastroenterology (1987) 1.44
Neutralization of poliovirus by antibody-mediated polymerization. Virology (1983) 1.38
Serum antibody responses to individual viral polypeptides in human rotavirus infections. J Gen Virol (1987) 1.31
Mechanisms of neutralization of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin. J Gen Virol (1990) 1.24
A monoclonal antibody that neutralizes poliovirus by cross-linking virions. J Virol (1985) 1.16
Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera. J Virol (1985) 1.12
NS35 and not vp7 is the soluble rotavirus protein which binds to target cells. J Virol (1990) 1.08
Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity. J Gen Virol (1982) 1.07
The surface nature of proteins of a bovine enterovirus, before and after neutralization. J Gen Virol (1976) 0.96
Neutralized vesicular stomatitis virus binds to host cells by a different "receptor". Biochem Biophys Res Commun (1983) 0.93
Immunogenicity of a bovine rotavirus glycoprotein fragment. J Virol (1985) 0.91
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis (1987) 4.64
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25
The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A (1988) 4.23
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol (1994) 4.21
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol (1977) 4.02
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Antigenic mapping of the surface proteins of rhesus rotavirus. Virology (1986) 3.80
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol (1985) 3.23
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Molecular basis of rotavirus virulence: role of gene segment 4. J Virol (1986) 3.08
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science (1996) 3.07
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J Virol (1986) 2.97
Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med (1976) 2.80
Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes. J Clin Microbiol (1992) 2.77
Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol (1988) 2.72
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63
Proteins of Norwalk virus. J Virol (1981) 2.59
Viral gastroenteritis. N Engl J Med (1991) 2.58
CCR7 expression and memory T cell diversity in humans. J Immunol (2001) 2.42
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis (1980) 2.39
Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest (2001) 2.23
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol (1988) 2.08
Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol (1979) 2.06
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol (1995) 2.06
Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis (1979) 2.05
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol (1994) 2.03
Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology (1988) 1.98
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis (1983) 1.94
Analysis of astrovirus serotype 1 RNA, identification of the viral RNA-dependent RNA polymerase motif, and expression of a viral structural protein. J Virol (1994) 1.94
The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology (1991) 1.92
Cultivation and characterization of three strains of murine rotavirus. J Virol (1986) 1.90
In vitro transcription of two human rotaviruses. J Virol (1982) 1.88
Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol (1990) 1.85
Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis. J Med Virol (1978) 1.84
Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. Gastroenterology (1979) 1.84
Rotavirus serotypes 6 and 10 predominate in cattle. J Clin Microbiol (1990) 1.81
Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol (1982) 1.81
The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol (1989) 1.80
Norwalk virus gastroenteritis following raw oyster consumption. Am J Epidemiol (1982) 1.77
Analyses of homologous rotavirus infection in the mouse model. Virology (1995) 1.75
Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun (1973) 1.72
Prevalence of antibody to the Norwalk agent by a newly developed immune adherence hemagglutination assay. J Med Virol (1978) 1.72
Molecular determinant of rotavirus neutralization and protection. Adv Virus Res (1989) 1.65
Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64
Immunity to homologous rotavirus infection in adult mice. Trends Microbiol (2000) 1.62
Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus. Virology (1993) 1.58
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol (1989) 1.58
Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol (1996) 1.56
Prevalence of antibody to the Norwalk virus in various countries. Infect Immun (1979) 1.54
Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis (2001) 1.54
Rotavirus VP7 neutralization epitopes of serotype 3 strains. Virology (1989) 1.54
Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J Virol (1990) 1.51
Expression of mucosal homing receptor alpha4beta7 by circulating CD4+ cells with memory for intestinal rotavirus. J Clin Invest (1997) 1.51
Identification and partial characterization of a rhesus rotavirus binding glycoprotein on murine enterocytes. Virology (1991) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells. J Virol (1991) 1.49
An outbreak of Norwalk gastroenteritis associated with swimming in a pool and secondary person-to-person transmission. Am J Epidemiol (1982) 1.47
Immunity to rotavirus in T cell deficient mice. Virology (1997) 1.47
Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J Infect Dis (1982) 1.46
Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J Clin Microbiol (1993) 1.46
Correlation of Australia antigen with posttransfusion hepatitis. JAMA (1970) 1.45
Epitope-specific immune responses to rotavirus vaccination. Gastroenterology (1987) 1.44
The epithelial cell response to rotavirus infection. J Immunol (1999) 1.44
Norwalk virus in vomitus. Lancet (1979) 1.42
Norwalk virus gastroenteritis aboard a cruise ship: an outbreak on five consecutive cruises. Am J Epidemiol (1980) 1.40
Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry. J Mol Biol (2001) 1.38
Norwalk virus enteric illness acquired by swimming exposure. Am J Epidemiol (1982) 1.38
Hepatitis G virus infection in hemodialysis patients and the effects of interferon treatment. Am J Gastroenterol (1997) 1.38
Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol (1990) 1.37
Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol (1993) 1.36
Calcium chelation induces a conformational change in recombinant herpes simplex virus-1-expressed rotavirus VP7. Virology (1992) 1.35
Two forms of VP7 are involved in assembly of SA11 rotavirus in endoplasmic reticulum. J Virol (1988) 1.34
Cloning and characterization of human astrovirus immunoreactive epitopes. J Virol (1993) 1.34
Norwalk gastroenteritis: a community outbreak associated with bakery product consumption. Ann Intern Med (1984) 1.33
Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core. J Virol (2001) 1.33
Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat Med (2000) 1.32